213 related articles for article (PubMed ID: 25106114)
1. Role of astrocytic glycolytic metabolism in Alzheimer's disease pathogenesis.
Fu W; Jhamandas JH
Biogerontology; 2014 Dec; 15(6):579-86. PubMed ID: 25106114
[TBL] [Abstract][Full Text] [Related]
2. Reactive astrocytes give neurons less support: implications for Alzheimer's disease.
Steele ML; Robinson SR
Neurobiol Aging; 2012 Feb; 33(2):423.e1-13. PubMed ID: 21051108
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease.
Zheng J; Xie Y; Ren L; Qi L; Wu L; Pan X; Zhou J; Chen Z; Liu L
Mol Metab; 2021 May; 47():101180. PubMed ID: 33556642
[TBL] [Abstract][Full Text] [Related]
4. Contribution of astrocytes to metabolic dysfunction in the Alzheimer's disease brain.
Zulfiqar S; Garg P; Nieweg K
Biol Chem; 2019 Aug; 400(9):1113-1127. PubMed ID: 31188740
[TBL] [Abstract][Full Text] [Related]
5. An inverse-Warburg effect and the origin of Alzheimer's disease.
Demetrius LA; Simon DK
Biogerontology; 2012 Dec; 13(6):583-94. PubMed ID: 23086530
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity.
Vincent AJ; Gasperini R; Foa L; Small DH
J Alzheimers Dis; 2010; 22(3):699-714. PubMed ID: 20847426
[TBL] [Abstract][Full Text] [Related]
7. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.
Avila-Muñoz E; Arias C
Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115
[TBL] [Abstract][Full Text] [Related]
8. Reactive Astrocytes as Drug Target in Alzheimer's Disease.
Assefa BT; Gebre AK; Altaye BM
Biomed Res Int; 2018; 2018():4160247. PubMed ID: 29888263
[TBL] [Abstract][Full Text] [Related]
9. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
[TBL] [Abstract][Full Text] [Related]
10. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
Kubo T; Nishimura S; Kumagae Y; Kaneko I
J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
[TBL] [Abstract][Full Text] [Related]
11. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
[TBL] [Abstract][Full Text] [Related]
12. The contribution of astrocytes to Alzheimer's disease.
Birch AM
Biochem Soc Trans; 2014 Oct; 42(5):1316-20. PubMed ID: 25233409
[TBL] [Abstract][Full Text] [Related]
13. Activated astrocytes: a therapeutic target in Alzheimer's disease?
Fuller S; Münch G; Steele M
Expert Rev Neurother; 2009 Nov; 9(11):1585-94. PubMed ID: 19903019
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures.
Sharma A; Kazim SF; Larson CS; Ramakrishnan A; Gray JD; McEwen BS; Rosenberg PA; Shen L; Pereira AC
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21800-21811. PubMed ID: 31591195
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.
Harris RA; Tindale L; Cumming RC
Biogerontology; 2014 Dec; 15(6):559-77. PubMed ID: 25305052
[TBL] [Abstract][Full Text] [Related]
18. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
Mattson MP
Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
[TBL] [Abstract][Full Text] [Related]
19. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.
Vardjan N; Verkhratsky A; Zorec R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208745
[TBL] [Abstract][Full Text] [Related]
20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
